These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3115785)

  • 1. Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy.
    Thomsen HS; Rasmussen D; Munck O; Lund JO; Gerhard-Nielsen V; Terkildsen T; Dombernowsky P; Andersen KW
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):779-81. PubMed ID: 3115785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of pre-scheduled bone scintigraphies in breast cancer.
    Thomsen HS; Lund JO; Munck O; Rossing N
    Acta Oncol; 1988; 27(6A):617-9. PubMed ID: 3146335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metastases in primary operable breast cancer. The role of serial scintigraphy.
    Thomsen HS; Lund JO; Munck O; Andersen KW; Støckel M; Rossing N
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1019-23. PubMed ID: 6540684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1].
    Thomsen HS; Andersen JA; Andersen KW; Axelsson CK; Blichert-Toft M; Dombernowsky P; Hansen M; Krag C; Mouridsen HT; Overgaard M
    Ugeskr Laeger; 1991 Aug; 153(33):2270-2. PubMed ID: 1781044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up.
    Butzelaar RM; van Dongen JA; de Graaf PW; van der Schoot JB
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):877-80. PubMed ID: 6540189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bone scintigraphy in the follow-up of osteogenic sarcoma.
    Körholz D; Wirtz I; Vosberg H; Rüther W; Jürgens H; Göbel U
    Eur J Cancer; 1996 Mar; 32A(3):461-4. PubMed ID: 8814693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone scintigraphy in breast cancer: a ten-year follow-up study.
    Crippa F; Seregni E; Agresti R; Bombardieri E; Buraggi GL
    J Nucl Biol Med (1991); 1993 Jun; 37(2):57-61. PubMed ID: 8373834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bone scans in the initial assessment of operable patients with breast carcinoma.
    Strender LE; Lagergren C; Wallgren A; Liljevall S
    Acta Radiol Oncol; 1981; 20(3):187-91. PubMed ID: 6270978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'For' or 'against' bone scintigraphy of patients with breast cancer.
    Derimanov SG
    Nucl Med Commun; 1987 Feb; 8(2):79-86. PubMed ID: 3587793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?
    Wikenheiser KA; Silberstein EB
    Cleve Clin J Med; 1996; 63(1):43-7. PubMed ID: 8590515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A re-evaluation of isotope screening for skeletal metastases in node-negative breast cancer.
    Gudgeon CA; Werner ID; Dent DM
    S Afr Med J; 1996 Feb; 86(2):166-9. PubMed ID: 8619145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone scanning: its lack of value in the follow-up of patients with breast cancer.
    Bishop HM; Blamey RW; Morris AH; Rose DH; Preston B; Lane J; Doyle PJ
    Br J Surg; 1979 Oct; 66(10):752-4. PubMed ID: 509054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone scintigraphy in breast cancer: a ten-year follow up study].
    Rajtár M; Esik O; Almási L; Csernay L
    Orv Hetil; 1990 Sep; 131(35):1907-8, 1911-2. PubMed ID: 2216412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of yearly chest X-ray in patients with stage I breast cancer.
    Vestergaard A; Herrstedt J; Thomsen HS; Dombernowsky P; Zedeler K
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):687-9. PubMed ID: 2714345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of bone marrow scintigraphy in patients with recurrent breast cancer].
    Langer SW; Kamby C; Thomsen HS; Sørensen T; Hvid-Jacobsen K; Dombernowsky P; Nielsen SL
    Ugeskr Laeger; 1993 Mar; 155(11):778-82. PubMed ID: 8460428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of routine bone scintigraphy in primary operable breast cancer].
    Thomsen HS; Munck O; Andersen KW
    Ugeskr Laeger; 1984 Jun; 146(26):1915-8. PubMed ID: 6506284
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of serial bone scanning in operable breast cancer.
    Monypenny IJ; Grieve RJ; Howell A; Morrison JM
    Br J Surg; 1984 Jun; 71(6):466-8. PubMed ID: 6722488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First repeated bone scan in the observation of patients with operable breast cancer.
    Pedrazzini A; Gelber R; Isley M; Castiglione M; Goldhirsch A
    J Clin Oncol; 1986 Mar; 4(3):389-94. PubMed ID: 3485185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of skeletal scintigraphy in the follow-up of breast cancer].
    Langhammer HR; Sondershaus S; Lauer O; Steuer G; Bauer R
    Fortschr Med; 1983 Mar; 101(10):429-34. PubMed ID: 6840646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.